178 related articles for article (PubMed ID: 23189201)
1. Pleckstrin homology domain of Akt kinase: a proof of principle for highly specific and effective non-enzymatic anti-cancer target.
Joh EH; Hollenbaugh JA; Kim B; Kim DH
PLoS One; 2012; 7(11):e50424. PubMed ID: 23189201
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Akt kinase activity by a peptide spanning the betaA strand of the proto-oncogene TCL1.
Hiromura M; Okada F; Obata T; Auguin D; Shibata T; Roumestand C; Noguchi M
J Biol Chem; 2004 Dec; 279(51):53407-18. PubMed ID: 15459205
[TBL] [Abstract][Full Text] [Related]
3. A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation.
Kim D; Sun M; He L; Zhou QH; Chen J; Sun XM; Bepler G; Sebti SM; Cheng JQ
J Biol Chem; 2010 Mar; 285(11):8383-94. PubMed ID: 20068047
[TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.
Meuillet EJ; Zuohe S; Lemos R; Ihle N; Kingston J; Watkins R; Moses SA; Zhang S; Du-Cuny L; Herbst R; Jacoby JJ; Zhou LL; Ahad AM; Mash EA; Kirkpatrick DL; Powis G
Mol Cancer Ther; 2010 Mar; 9(3):706-17. PubMed ID: 20197390
[TBL] [Abstract][Full Text] [Related]
5. Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain.
Meuillet EJ
Curr Med Chem; 2011; 18(18):2727-42. PubMed ID: 21649580
[TBL] [Abstract][Full Text] [Related]
6. Regulation of AKT Activity by Inhibition of the Pleckstrin Homology Domain-PtdIns(3,4,5)P
Kang Y; Jang G; Ahn S; Lee Y; Shim SY; Yoon Y
J Microbiol Biotechnol; 2018 Aug; 28(8):1401-1411. PubMed ID: 30301316
[TBL] [Abstract][Full Text] [Related]
7. Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.
Chen G; Park D; Magis AT; Behera M; Ramalingam SS; Owonikoko TK; Sica GL; Ye K; Zhang C; Chen Z; Curran WJ; Deng X
Cancer Res; 2019 Dec; 79(24):6126-6138. PubMed ID: 31662324
[TBL] [Abstract][Full Text] [Related]
8. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
9. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells.
Estrada AC; Syrovets T; Pitterle K; Lunov O; Büchele B; Schimana-Pfeifer J; Schmidt T; Morad SA; Simmet T
Mol Pharmacol; 2010 Mar; 77(3):378-87. PubMed ID: 20018812
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel class of AKT pleckstrin homology domain inhibitors.
Mahadevan D; Powis G; Mash EA; George B; Gokhale VM; Zhang S; Shakalya K; Du-Cuny L; Berggren M; Ali MA; Jana U; Ihle N; Moses S; Franklin C; Narayan S; Shirahatti N; Meuillet EJ
Mol Cancer Ther; 2008 Sep; 7(9):2621-32. PubMed ID: 18790745
[TBL] [Abstract][Full Text] [Related]
11. Deactivation of Akt by a small molecule inhibitor targeting pleckstrin homology domain and facilitating Akt ubiquitination.
Jo H; Lo PK; Li Y; Loison F; Green S; Wang J; Silberstein LE; Ye K; Chen H; Luo HR
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6486-91. PubMed ID: 21464312
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT.
Moses SA; Ali MA; Zuohe S; Du-Cuny L; Zhou LL; Lemos R; Ihle N; Skillman AG; Zhang S; Mash EA; Powis G; Meuillet EJ
Cancer Res; 2009 Jun; 69(12):5073-81. PubMed ID: 19491272
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E facilitates the inactivation of the kinase Akt by the phosphatase PHLPP1.
Huang PH; Chuang HC; Chou CC; Wang H; Lee SL; Yang HC; Chiu HC; Kapuriya N; Wang D; Kulp SK; Chen CS
Sci Signal; 2013 Mar; 6(267):ra19. PubMed ID: 23512990
[TBL] [Abstract][Full Text] [Related]
14. Anti-breast cancer and toxicity studies of total secondary saponin from Anemone raddeana Rhizome on MCF-7 cells via ROS generation and PI3K/AKT/mTOR inactivation.
Zhang D; Zhang Q; Zheng Y; Lu J
J Ethnopharmacol; 2020 Sep; 259():112984. PubMed ID: 32446927
[TBL] [Abstract][Full Text] [Related]
15. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
[TBL] [Abstract][Full Text] [Related]
16. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121.
Peng Y; Zhou Y; Cheng L; Hu D; Zhou X; Wang Z; Xie C; Zhou F
Biochem Biophys Res Commun; 2015 Sep; 465(1):137-44. PubMed ID: 26235881
[TBL] [Abstract][Full Text] [Related]
17. Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analogues.
Castillo SS; Brognard J; Petukhov PA; Zhang C; Tsurutani J; Granville CA; Li M; Jung M; West KA; Gills JG; Kozikowski AP; Dennis PA
Cancer Res; 2004 Apr; 64(8):2782-92. PubMed ID: 15087394
[TBL] [Abstract][Full Text] [Related]
18. A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor.
Boran AD; Seco J; Jayaraman V; Jayaraman G; Zhao S; Reddy S; Chen Y; Iyengar R
PLoS One; 2012; 7(11):e49702. PubMed ID: 23166750
[TBL] [Abstract][Full Text] [Related]
19. BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models.
Politz O; Siegel F; Bärfacker L; Bömer U; Hägebarth A; Scott WJ; Michels M; Ince S; Neuhaus R; Meyer K; Fernández-Montalván AE; Liu N; von Nussbaum F; Mumberg D; Ziegelbauer K
Int J Cancer; 2017 Jan; 140(2):449-459. PubMed ID: 27699769
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition.
Wu WI; Voegtli WC; Sturgis HL; Dizon FP; Vigers GP; Brandhuber BJ
PLoS One; 2010 Sep; 5(9):e12913. PubMed ID: 20886116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
